As manager of Pew's drug safety project, Cosel works on federal initiatives to ensure the safety and oversight of the U.S. pharmaceutical supply chain. Prior to joining Pew, Cosel worked on issues of pharmaceutical safety and appropriate prescribing for national advocacy Organization Community Catalyst, and in grassroots development and capacity-building with the Fund for Public Interest Research in Cambridge, Massachusetts.
Cosel received her M.Sc. in human rights from the London School of Economics and a BA from Yale University.
Recent WorkView All
On November 20, The Pew Charitable Trusts—joined by the American Public Health Association, the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Pharmaceutical Research and Manufacturers of America, and Trust for America’s Health—sent a letter to the Food and Drug Administration (FDA) supporting their enforcement of federal law on drug... Read More
Each November, the U.S. Centers for Disease Control and Prevention observes Get Smart About Antibiotics Week, a campaign to raise awareness of the escalating threat of antibiotic resistance and the measures that people can take to preserve the effectiveness of these critical drugs. Since last year’s Get Smart week, policymakers and other stakeholders in the U.S. and abroad have... Read More
When compounded drugs are created in large volumes and shipped across the country, as was the case with injections linked to the national meningitis outbreak, producers should meet some of the same quality assurance requirements as drug manufacturers. Read More